title: Pergolide and valvular heart disease: the lower the better?
authors.forename: Steven
authors.initials: S
authors.lastname: Droogmans
authors.forename: Bernard
authors.initials: B
authors.lastname: Cosyns
authors.forename: Guy
authors.initials: G
authors.lastname: Van Camp
mesh_terms: D018491:Dopamine Agonists / Q000008:administration & dosage* / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D006349:Heart Valve Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy; D010479:Pergolide / Q000008:administration & dosage* / Q000009:adverse effects*; D017410:Practice Guidelines as Topic; D012148:Restless Legs Syndrome / Q000188:drug therapy; D014463:Ultrasonography
chemical_list: D018491:Dopamine Agonists; D010479:Pergolide